Physician
Mark Malone MD PA
Mark Malone MD PA was paid $1.27M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 82% of everything it billed.
33Billing provider infoMARK MALONE MD PA
ROUND ROCK, TX 78664
ROUND ROCK, TX 78664
33aNPI1407057250assigned 05/30/2007
33bProvider typeAnesthesiology Physician
28Total paid$1.27M
24GClaims51,058
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anesthesiology Physician providers in Texas
Rank by total paid#23 of 134
Median peer was paid$34K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,701 | $34K | |
| 2019 | 8,222 | $49K | |
| 2020 | 5,249 | $45K | |
| 2021 | 6,193 | $170K | |
| 2022 | 8,364 | $321K | |
| 2023 | 9,560 | $454K | |
| 2024incomplete | 4,769 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 82% | 28,441 | 26,562 | $1.04M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.9% | 9,834 | 9,453 | $125K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 3.9% | 5,709 | 5,547 | $49K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.8% | 932 | 894 | $23K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 1,815 | 1,769 | $12K |
| 99442 | <1% | 191 | 186 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 78 | 68 | $4K |
| 01936 | <1% | 97 | 91 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 26 | 25 | $1K |
| 01992 | <1% | 13 | 13 | $1K | |
| 99443 | <1% | 14 | 13 | $1K | |
| 99406 | <1% | 138 | 118 | $368.94 |
35 more codes
| 96127 | <1% | 1,743 | $362.35 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $359.09 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 50 | $78.35 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 936 | $72.89 |
| 99490 | Ccm add 20min | <1% | 196 | $24.92 |
| 80363 | <1% | 17 | $17.83 | |
| 80361 | <1% | 17 | $14.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $14.28 |
| 83992 | <1% | 17 | $14.11 | |
| 80348 | <1% | 17 | $13.74 | |
| 80346 | <1% | 17 | $13.53 | |
| 80356 | <1% | 17 | $13.36 | |
| 80354 | <1% | 17 | $12.81 | |
| 80365 | <1% | 17 | $11.91 | |
| 80349 | <1% | 17 | $11.27 | |
| 80358 | <1% | 17 | $11.02 | |
| 80325 | <1% | 17 | $10.92 | |
| 80372 | <1% | 17 | $10.62 | |
| 80367 | <1% | 17 | $10.51 | |
| 80373 | <1% | 17 | $10.33 | |
| 80357 | <1% | 17 | $10.33 | |
| 80353 | <1% | 17 | $10.25 | |
| 80370 | <1% | 17 | $9.90 | |
| 80360 | <1% | 17 | $9.11 | |
| 80368 | <1% | 17 | $8.82 | |
| 80359 | <1% | 17 | $8.50 | |
| 80355 | <1% | 15 | $7.71 | |
| 80366 | <1% | 15 | $6.93 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 28 | $2.93 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 166 | $1.27 |
| 72100 | 0% | 12 | $0.00 | |
| G9655 | A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used | 0% | 95 | $0.00 |
| G9656 | Patient transferred directly from anesthetizing location to pacu or other non-icu location | 0% | 95 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 12 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSONS, CHRISTINA (CHIEF ADMINISTRATIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Round Rock Surgery Center LLC | Round Rock, TX | $2K |
| Apc-Amarillo Surgical Operating Company, LLC | Amarillo, TX | $384.35 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.